Skip to main content

Advertisement

Table 1 Comparison of the clinical parameters between the two groups of patients with hepatocellular carcinoma (HCC)

From: Transcatheter arterial chemoembolization combined with CT-guided percutaneous thermal ablation versus hepatectomy in the treatment of hepatocellular carcinoma

Matched variable Combination group (n = 137) Surgery group (n = 148) P
Age (years)    0.093
  Median 51 54  
  Range 23–74 23–75  
Sexa    0.183
  Male 129 133  
  Female 8 15  
Hypersplenisma    0.281
  Yes 74 70  
  No 63 78  
Child-Pugh classa    0.193
  A 124 140  
  B 13 8  
Cirrhosisa    0.432
  Yes 118 132  
  No 19 16  
Diabetes mellitusa    0.296
  No 118 134  
  Yes 19 14  
Tumor numbera    0.582
  1 59 69  
  2 43 50  
  3 28 21  
  4 7 8  
Tumor sizea    0.992
  ≤3 cm 61 68  
  >3 cm and ≤5 cm 47 49  
  >5 cm and ≤7 cm 23 24  
  >7 cm and ≤10 cm 6 7  
Alpha fetoproteina    0.292
  ≥400 ng/mL 34 45  
  <400 ng/mL 103 103  
Size of all nodules in diameter (cm)    0.364
  Median 3.8 4.0  
  Mean ± standard deviation 37.0 ± 17.5 38.9 ± 18.1  
Albumin (g/L) 40.8 ± 4.3 41.6 ± 4.2 0.133
Prothrombin time (s) 12.6 ± 2.0 13.0 ± 2.1 0.075
Platelet count (×109/L) 128.2 ± 64.8 145.1 ± 60.0 0.022
Hemoglobin (g/L) 135.9 ± 16.2 138.7 ± 16.8 0.156
CA19-9 (U/mL) 140.4 ± 852.2 79.8 ± 531.0 0.469
  1. aThe values are presented as number of patients. Tumor size, the largest lesion in diameter.